These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
458 related articles for article (PubMed ID: 32098318)
1. Beyond IgE: Alternative Mast Cell Activation Across Different Disease States. Lyons DO; Pullen NA Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098318 [TBL] [Abstract][Full Text] [Related]
2. Soluble transforming growth factor beta-1 enhances murine mast cell release of Interleukin 6 in IgE-independent and Interleukin 13 in IgE-dependent settings in vitro. Lyons DO; Plewes MR; Pullen NA PLoS One; 2018; 13(11):e0207704. PubMed ID: 30444930 [TBL] [Abstract][Full Text] [Related]
4. IgE and IgG Antibodies as Regulators of Mast Cell and Basophil Functions in Food Allergy. Kanagaratham C; El Ansari YS; Lewis OL; Oettgen HC Front Immunol; 2020; 11():603050. PubMed ID: 33362785 [TBL] [Abstract][Full Text] [Related]
5. Mast cell mediated ion transport in intestine from patients with and without inflammatory bowel disease. Crowe SE; Luthra GK; Perdue MH Gut; 1997 Dec; 41(6):785-92. PubMed ID: 9462211 [TBL] [Abstract][Full Text] [Related]
6. Influence of IL-6, IL-33, and TNF-α on human mast cell activation: Lessons from single cell analysis by flow cytometry. Cop N; Ebo DG; Bridts CH; Elst J; Hagendorens MM; Mertens C; Faber MA; De Clerck LS; Sabato V Cytometry B Clin Cytom; 2018 May; 94(3):405-411. PubMed ID: 28802100 [TBL] [Abstract][Full Text] [Related]
7. IL-10 Differentially Promotes Mast Cell Responsiveness to IL-33, Resulting in Enhancement of Type 2 Inflammation and Suppression of Neutrophilia. Ranjitkar S; Krajewski D; Garcia C; Tedeschi C; Polukort SH; Rovatti J; Mire M; Blesso CN; Jellison E; Schneider SS; Ryan JJ; Mathias CB J Immunol; 2024 May; 212(9):1407-1419. PubMed ID: 38497670 [TBL] [Abstract][Full Text] [Related]
8. Mast cells and immunoglobulin E in inflammatory bowel disease. Lloyd G; Green FH; Fox H; Mani V; Turnberg LA Gut; 1975 Nov; 16(11):861-5. PubMed ID: 1238311 [TBL] [Abstract][Full Text] [Related]
9. Divergent Effects of Acute and Prolonged Interleukin 33 Exposure on Mast Cell IgE-Mediated Functions. Rönnberg E; Ghaib A; Ceriol C; Enoksson M; Arock M; Säfholm J; Ekoff M; Nilsson G Front Immunol; 2019; 10():1361. PubMed ID: 31275312 [No Abstract] [Full Text] [Related]
10. IL-33 is produced by mast cells and regulates IgE-dependent inflammation. Hsu CL; Neilsen CV; Bryce PJ PLoS One; 2010 Aug; 5(8):e11944. PubMed ID: 20689814 [TBL] [Abstract][Full Text] [Related]
11. IgE promotes type 2 innate lymphoid cells in murine food allergy. Burton OT; Medina Tamayo J; Stranks AJ; Miller S; Koleoglou KJ; Weinberg EO; Oettgen HC Clin Exp Allergy; 2018 Mar; 48(3):288-296. PubMed ID: 29247574 [TBL] [Abstract][Full Text] [Related]
12. IL-9-producing cells in the development of IgE-mediated food allergy. Shik D; Tomar S; Lee JB; Chen CY; Smith A; Wang YH Semin Immunopathol; 2017 Jan; 39(1):69-77. PubMed ID: 27909880 [TBL] [Abstract][Full Text] [Related]
13. Histamine release from gut mast cells from patients with inflammatory bowel diseases. Nolte H; Spjeldnaes N; Kruse A; Windelborg B Gut; 1990 Jul; 31(7):791-4. PubMed ID: 1695160 [TBL] [Abstract][Full Text] [Related]
14. The interleukin-33 receptor ST2 is important for the development of peripheral airway hyperresponsiveness and inflammation in a house dust mite mouse model of asthma. Zoltowska AM; Lei Y; Fuchs B; Rask C; Adner M; Nilsson GP Clin Exp Allergy; 2016 Mar; 46(3):479-90. PubMed ID: 26609909 [TBL] [Abstract][Full Text] [Related]
15. Formononetin inhibits IgE by huPlasma/PBMCs and mast cells/basophil activation via JAK/STAT/PI3-Akt pathways. Musa I; Wang ZZ; Yang N; Li XM Front Immunol; 2024; 15():1427563. PubMed ID: 39221239 [TBL] [Abstract][Full Text] [Related]
16. Human colonic anti-secretory activity of the potent NK(1) antagonist, SR140333: assessment of potential anti-diarrhoeal activity in food allergy and inflammatory bowel disease. Moriarty D; Goldhill J; Selve N; O'Donoghue DP; Baird AW Br J Pharmacol; 2001 Aug; 133(8):1346-54. PubMed ID: 11498521 [TBL] [Abstract][Full Text] [Related]
17. Regulatory T cells enhance mast cell production of IL-6 via surface-bound TGF-β. Ganeshan K; Bryce PJ J Immunol; 2012 Jan; 188(2):594-603. PubMed ID: 22156492 [TBL] [Abstract][Full Text] [Related]
18. IL-33/ST2 signalling and crosstalk with FcεRI and TLR4 is targeted by the parasitic worm product, ES-62. Ball DH; Al-Riyami L; Harnett W; Harnett MM Sci Rep; 2018 Mar; 8(1):4497. PubMed ID: 29540770 [TBL] [Abstract][Full Text] [Related]
19. IgE and Mast Cells: The Endogenous Adjuvant. Oettgen HC; Burton OT Adv Immunol; 2015; 127():203-56. PubMed ID: 26073985 [TBL] [Abstract][Full Text] [Related]
20. The Role of Mast Cells in IgE-Independent Lung Diseases. Komi DEA; Mortaz E; Amani S; Tiotiu A; Folkerts G; Adcock IM Clin Rev Allergy Immunol; 2020 Jun; 58(3):377-387. PubMed ID: 32086776 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]